<DOC>
	<DOCNO>NCT01606033</DOCNO>
	<brief_summary>This study aim assess anxiety/depression life quality patient include clinical trial versus patient treat standard way .</brief_summary>
	<brief_title>Study Stress Life Quality Patients Participating Clinical Trials Versus Patients Non Participating</brief_title>
	<detailed_description>This study aim assess anxiety/depression life quality patient include clinical trial versus patient treat standard way A case-control study</detailed_description>
	<mesh_term>Hematologic Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>patient solid tumor recurrent hematologic cancer , treat chemotherapy target therapy evaluate every 2 3 cycle ; except clinical trial associate non drug treatment ( radiotherapy , surgery ... ) subject 1st , 2nd 3rd line antitumor treatment phase 2 open label study , phase 2 3 blind randomise study , phase 2 3 open randomise study , standard treatment non participate clinical trial male female patient ≥ 18 year age karnovsky ≥ 70 % OMS ≤ 2 recover prior toxicity social security cover write informed consent give psychiatric disorder , receive psychotropic treatment physical psychological issue forbid include study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stress</keyword>
	<keyword>Life quality</keyword>
	<keyword>adjustment strategy</keyword>
	<keyword>receive antitumor treatment</keyword>
	<keyword>within clinical trial ( case )</keyword>
	<keyword>accord standard treatment ( control )</keyword>
</DOC>